Abstract
Several genes have been associated with breast cancer (BC) susceptibility. The tumor necrosis factor receptor superfamily, member 1A (TNFRSF1A), and interferon lambda receptor 1 (IFNLR1) genes encode receptors that mediate the action of inflammatory cytokines. Previous studies have demonstrated the association of the variants rs1800693 (TNFRSF1A) and rs4649203 (IFNLR1) with some inflammatory diseases. The present study aimed to verify a possible association of these variants with BC, its clinical pathologic features, as well as epidemiological data in a Brazilian population. A total of 243 patients and 294 individuals without history of BC were genotyped for these polymorphisms through TaqMan® SNP genotyping assays by qPCR. For the TNFRSF1A gene, no significant results were found. For IFNLR1, the AA genotype (p = 0.008) and the A allele (p = 0.02) were significantly associated with a lower risk of developing BC. When analyzing the age, it was observed that each increase of one year contributes to the development of BC (p < 0.001). Also, the smoking habit (p < 0.001) and body mass index (p = 0.018) increase the risk of disease development. Analyzing progesterone receptor factor an association was found with the AA genotype of the IFNLR1 (p = 0.02). The findings suggest that polymorphism in the immune-related IFNLR1 gene contribute to BC susceptibility in a Brazilian population. These findings can contribute to the further understanding of the role this gene and pathways in BC development.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ahn J, Schatzkin A Jr, JVL, et al (2007) Adiposity, Adult Weight Change, and Postmenopausal Breast Cancer. Risk 167:2091–2102
Barros AJD, Hirakata VN (2003) Alternatives for logistic regression in cross-sectional studies: An empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol 3:1–13. https://doi.org/10.1186/1471-2288-3-21
Ben-Baruch A (2003) Host microenvironment in breast cancer development. Inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions. Breast Cancer Res 5:31–36. https://doi.org/10.1186/bcr554
Borgquist S, Jirstr K (2009) Anthropometric factors in relation to different tumor biological subgroups of postmenopausal breast cancer. Int J Cancer 411:402–411. https://doi.org/10.1002/ijc.23850
Brand S, Beigel F, Olszak T, et al (2005) IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression. J Physiol Gastrointest Liver Physiol 289(5):G960–G968 (2005)
Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424. https://doi.org/10.3322/caac.21492
Cai H, Zhou Y, Jia W et al (2015) Effects of SNPs and alternative splicing within HGF gene on its expression patterns in Qinchuan cattle. J Anim Sci Biotechnol 6:55. https://doi.org/10.1186/s40104-015-0059-3
Cheng YY, Sheng YJ, Chang Y et al (2015) Increased expression of IL-28RA mRNA in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clin Rheumatol 34:1807–1811. https://doi.org/10.1007/s10067-015-2947-5
Chlebowski RT, Manson JE, Anderson GL et al (2013) Estrogen plus progestin and breast cancer incidence and mortality in the women’ s health initiative observational study. J Natl Cancer Inst. https://doi.org/10.1093/jnci/djt043
Comabella M, Caminero AB, Malhotra S et al (2013) TNFRSF1A polymorphisms rs1800693 and rs4149584 in patients with multiple sclerosis. Neurology 80:2010–2016. https://doi.org/10.1212/WNL.0b013e318294b2d6
Dashti M, Ateyah K, Alroughani R, Al-temaimi R (2020) Replication analysis of variants associated with multiple sclerosis risk. Sci Rep. https://doi.org/10.1038/s41598-020-64432-3
de Groen RA, Liu B-S, Boonstra A (2014) Understanding IFNλ in rheumatoid arthritis. Arthritis Res Ther 16:102. https://doi.org/10.1186/ar4445
De Jager PL, Jia X, Wang J et al (2009) Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet 41:776–782. https://doi.org/10.1038/ng.401
de Kruijf EM, Sajet A, van Nes JGH et al (2010) HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients. J Immunol 185:7452–7459. https://doi.org/10.4049/jimmunol.1002629
Dhiman N, Haralambieva IH, Kennedy RB et al (2010) SNP/haplotype associations in cytokine and cytokine receptor genes and immunity to rubella vaccine. Immunogenetics 62:197–210. https://doi.org/10.1007/s00251-010-0423-6
Elinav E, Nowarski R, Thaiss CA et al (2013) Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer 13:759–771. https://doi.org/10.1038/nrc3611
García-Tuñón I, Ricote M, Ruiz A et al (2006) Role of tumor necrosis factor-α and its receptors in human benign breast lesions and tumors (in.situ and infiltrative). Cancer Sci 97:1044–1049. https://doi.org/10.1111/j.1349-7006.2006.00277.x
Gonzalez H, Hagerling C, Werb Z (2018) Roles of the immune system in cancer: From tumor initiation to metastatic progression. Genes Dev 32:1267–1284. https://doi.org/10.1101/GAD.314617.118
Gregory AP, Dendrou CA, Attfield KE et al (2012) TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. Nature 488:508–511. https://doi.org/10.1038/nature11307
Griffiths SJ, Dunnigan CM, Russell CD, Haas JG (2015) The role of interferon-λ locus polymorphisms in Hepatitis C and other infectious diseases. J Innate Immun 7:231–242. https://doi.org/10.1159/000369902
Hengeveld PJ, Kersten MJ (2015) B-cell activating factor in the pathophysiology of multiple myeloma: a target for therapy? Blood Cancer J 5:e282–e288. https://doi.org/10.1038/bcj.2015.3
Hoffjan S, Okur A, Epplen JT et al (2015) Association of TNFAIP3 and TNFRSF1A variation with multiple sclerosis in a German case-control cohort. Int J Immunogenet 42:106–110. https://doi.org/10.1111/iji.12183
Instituto Nacional de Câncer José Alencar Gomes da Silva (2019) Estimativa 2020 : incidência de câncer no Brasil
Iyengar NM, Hudis CA, Dannenberg AJ (2015) Obesity and cancer: local and systemic mechanisms. Annu Rev Med 66:297–309. https://doi.org/10.1146/annurev-med-050913-022228
Javor J, Shawkatová I, Ďurmanová V et al (2018) TNFRSF1A polymorphisms and their role in multiple sclerosis susceptibility and severity in the Slovak population. Int J Immunogenet 45:257–265. https://doi.org/10.1111/iji.12388
Jiang L, Wang J, Gao X, Liu S (2017) Association of TNF-α, TNFRSF1A and TNFRSF1B gene polymorphisms with the risk of gastric cancer in Chinese population. Int J Clin Exp Med 10:12483–12491
Jones ME, Schoemaker MJ, Wright LB et al (2017) Smoking and risk of breast cancer in the Generations Study cohort. Breast Cancer Res. https://doi.org/10.1186/s13058-017-0908-4
Katzke VA, Kaaks R, Kühn T (2015) Lifestyle and cancer risk. Cancer J 21(2):104–10
Kulakova OG, Bashinskaya V, Tsareva EY et al (2018) Analysis of associations of polymorphisms of genes encoding cytokine receptors with the clinical features of multiple sclerosis. Neurosci Behav Physiol 48:337–341. https://doi.org/10.1007/s11055-018-0567-7
Li M, Liu X, Zhou Y, Su SB (2009) Interferon-λs: the modulators of antivirus, antitumor, and immune responses. J Leukoc Biol 86:23–32. https://doi.org/10.1189/jlb.1208761
Li Y, Cheng H, Zuo X, et al (2013) Association analyses identifying two common susceptibility loci shared by psoriasis and systemic lupus erythematosus in the Chinese Han population. 812–818. https://doi.org/https://doi.org/10.1136/jmedgenet-2013-101787
Lopez de Lapuente A, Alloza I, Goertsches R et al (2012) Analysis of the IL28RA locus as genetic risk factor for multiple sclerosis. J Neuroimmunol 245:98–101. https://doi.org/10.1016/j.jneuroim.2012.02.005
Lu H, Ouyang W, Huang C (2006) Inflammation, a key event in cancer development. Mol Cancer Res 4:221–233. https://doi.org/10.1158/1541-7786.MCR-05-0261
Luo J, Margolis KL, Wactawski-wende J et al (2011) Association of active and passive smoking with risk of breast cancer among postmenopausal women : a prospective cohort study. Br Med J. https://doi.org/10.1136/bmj.d1016
Ma N, Zhang X, Yang L et al (2017) Role of functional IFNL4, IFNLR1, IFNA, IFNAR2 polymorphisms in Hepatitis B virus-related liver disease in Han Chinese population. J Viral Hepat 25:306–313. https://doi.org/10.1111/jvh.12817
Macacu A, Autier P, Boniol M, Boyle P (2015) Active and passive smoking and risk of breast cancer : a meta-analysis. Breast Cancer Res Treat. https://doi.org/10.1007/s10549-015-3628-4
Meager A, Visvalingam K, Dilger P, et al (2005) Biological activity of interleukins-28 and -29 : Comparison with type I interferons. https://doi.org/https://doi.org/10.1016/j.cyto.2005.04.003
Moudgil KD, Choubey D (2011) Cytokines in autoimmunity: role in induction, regulation, and treatment. J Interf Cytokine Res 31:695–703. https://doi.org/10.1089/jir.2011.0065
Numasaki M, Tagawa M, Iwata F et al (2007) IL-28 elicits antitumor responses against murine fibrosarcoma. J Immunol 178:5086–5098. https://doi.org/10.4049/jimmunol.178.8.5086
Parcesepe P, Giordano G, Laudanna C et al (2016) Cancer-associated immune resistance and evasion of immune surveillance in colorectal cancer. Gastroenterol Res Pract. https://doi.org/10.1155/2016/6261721
Park TJ, Kim HJ, Kim JH et al (2013) Associations of CD6, TNFRSF1A and IRF8 polymorphisms with risk of inflammatory demyelinating diseases. Neuropathol Appl Neurobiol 39:519–530. https://doi.org/10.1111/j.1365-2990.2012.01304.x
Pinheiro AB, Barreto-Neto NJS, Rio JA, et al (2015) Associação entre índice de massa corpórea e câncer de mama em pacientes de Salvador , Bahia
Rakha EA, El-sayed ME, Green AR et al (2019) Biologic and clinical characteristics of breast cancer with single hormone receptor–Positive Phenotype. J Clin Oncol. https://doi.org/10.1200/JCO.2007.12.2747
Rousset F, Raymond M (1995) Sweat chloride testing in infants identified as heterozygote carriers by newborn screening. Genet Soc Am 140:1413–1419. https://doi.org/10.1016/j.jpeds.2008.07.054
Scott IC, Seegobin SD, Steer S et al (2013) Predicting the risk of rheumatoid arthritis and its age of onset through modelling genetic risk variants with smoking. PLoS ONE. https://doi.org/10.1371/journal.pgen.1003808
Shao XQ, Ding XL, Mu K et al (2018) Associations of TNFRSF1A polymorphisms with autoimmune thyroid diseases: a case-control study. Horm Metab Res 50:117–123. https://doi.org/10.1055/s-0043-124435
Sheppard P, Kindsvogel W, Xu W et al (2003) IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 4:63–68. https://doi.org/10.1038/ni873
Stendahl M, Rydén L, Nordenskjöld B et al (2006) High progesterone receptor expression correlates to the effect of adjuvant tamoxifen in premenopausal breast cancer patients. Clin Cancer Res 12:4614–4618. https://doi.org/10.1158/1078-0432.CCR-06-0248
Strange A, Capon F, Spencer CC et al (2010a) Genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1 Genetic Analysis of Psoriasis Consortium and the Wellcome Trust Case Control Consortium 2 *. Nat Genet 42:985–990. https://doi.org/10.1038/ng.694
Strange A, Capon F, Spencer CCA et al (2010b) Genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet 42:985–990. https://doi.org/10.1038/ng.694.Genome-wide
The Union International Cancer Control (2018) New Global Cancer Data: GLOBOCAN 2018 | UICC. Geneva, Switzerland, 12 Sept 2018 1
Watts L, Karaderi T, Roberts A et al (2019) The severity of ankylosing spondylitis and responses to anti-tumour necrosis factor biologics are not influenced by the tumour necrosis factor receptor polymorphism incriminated in multiple sclerosis. Genes Immun 20:167–171. https://doi.org/10.1038/s41435-018-0017-0
Winters S, Martin C, Murphy D, Shokar NK (2017) Breast cancer epidemiology, prevention, and screening. Elsevier, Amsterdm
Xu F, Zhou G, Han S et al (2014) Association of TNF-α, TNFRSF1A and TNFRSF1B gene polymorphisms with the risk of sporadic breast cancer in northeast Chinese Han women. PLoS ONE. https://doi.org/10.1371/journal.pone.0101138
Yang L, Luo Y, Wei J, He S (2010a) Integrative genomic analyses on IL28RA , the common receptor of interferon- Ï 1 , - Ï 2 and - Ï 3. 807–812. https://doi.org/https://doi.org/10.3892/ijmm
Yang L, LUO Y, WEI J, HE S, (2010) Integrative genomic analyses on IL28RA, the common receptor of interferon-λ1, -λ2 and -λ3. Int J Mol Med 25:807–812. https://doi.org/10.3892/ijmm_00000408
Yang Q, Liu H, Qu L et al (2013) Investigation of 20 non-HLA (human leucocyte antigen) psoriasis susceptibility loci in Chinese patients with psoriatic arthritis and psoriasis vulgaris. Br J Dermatol 168:1060–1065. https://doi.org/10.1111/bjd.12142
Zitzmann K, Brand S, Baehs S et al (2006) Novel interferon- k s induce antiproliferative effects in neuroendocrine tumor cells 344:1334–1341. https://doi.org/10.1016/j.bbrc.2006.04.043
Funding
This study was funded by CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior) Grant Number 23038.008120/2010–11 and by FAPESC (Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina) number Nº 07/2013 MS-DECIT/CNPq/SES-SC.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declared no potential conflict of interests with respect to the research, authorship, and/or publication of this article.
Ethical Approval
This work is part of a project approved by the Human Research Ethics Committee of the Universidade Federal de Santa Catatina (CEPSH-UFSC), protocol nº 922.167.
Consent to Participate
Only the women who agreed to participate and gave their written informed consent were included in this study.
Consent for Publication
We confirm that the manuscript has been read and approved by all named authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Hausmann, L.D., de Almeida, B.S., de Souza, I.R. et al. Association of TNFRSF1A and IFNLR1 Gene Polymorphisms with the Risk of Developing Breast Cancer and Clinical Pathologic Features. Biochem Genet 59, 1233–1246 (2021). https://doi.org/10.1007/s10528-021-10060-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10528-021-10060-z